Is daily supervised buprenorphine-naloxone dosing necessary?

Kleinman, Robert A; Nielsen, Suzanne; Weiss, Roger D

Kleinman, Robert A; Nielsen, Suzanne; Weiss, Roger D.

Kleinman RA; Centre for Addiction and Mental Health, Toronto, ON, Canada robert.kleinman@camh.ca.
Nielsen S; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Weiss RD; Monash Addiction Research Centre, Monash University, Melbourne, Australia.

BMJ ; 378: e071467, 2022 08 16.

Article in English | MEDLINE | ID: covidwho-1992993

Subject(s)

Buprenorphine; Opioid-Related Disorders; Buprenorphine/therapeutic use; Buprenorphine, Naloxone Drug Combination/therapeutic use; Humans; Naloxone/therapeutic use; Narcotic Antagonists/therapeutic use; Opioid-Related Disorders/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Buprenorphine / Opioid-Related Disorders Limits: Humans Language: English Journal: BMJ Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: Bmj-2022-071467

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google